IL6 and Parkinson disease: The role of chronic inflammation is substantiated by a growing body of evidence in Parkinson's disease, where raised inflammatory markers, such as interleukin-6 and tumor necrosis factor-alpha, have been observed in association with greater severity of fatigue.